Skip to content

XIV International HIV Drug Resistance Workshop: Subtypes, resistance pathways and implications for therapy

XIV International HIV Drug Resistance Workshop: preventing mother-to-child transmission

Rifampicin resistance linked to dosing schedule in HIV-positive TB patients

Standard tests underestimate resistance in mothers who received nevirapine when giving birth

Are changing treatment guidelines responsible for differing rates of transmitted drug resistance?

HIV-1 and HIV-2 coinfection: viral response to HAART differs

Drug-resistant HIV infections not rising in France

Benefits of genotypic testing confirmed in French clinic study

The New York resistance case: details published in The Lancet